Depression in women

Clinical Obstetrics and Gynecology

Volumn 40, Issue 3, 1997, Pages 577-588

  Fishman, Risa ^a   Downey, Jennifer ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; VENLAFAXINE;

CONFERENCE PAPER; DEPRESSION; DISEASE CLASSIFICATION; DYSTHYMIA; HUMAN; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; WOMEN'S HEALTH;

EID: 0031414792     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199709000-00018     Document Type: Conference Paper

References (17)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Study. Arch Gen Psychiatr. 1994; 51:8-19.
2. Williams JBW, Spitzer RL, Linzer M, et al. Gender differences in depression in primary care. Am J Obstet Gynecol. 1995;173:654-659.
3. Tylee A, Freeling P, Kerry S, et al. How does the content of consultations affect the recognition by general practitioners of major depression in women? Br J Gen Pract. 1995;45:575-578.
4. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington: American Psychiatric Association, 1994.
5. Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatr, 1992;49:769-773.
6. Coryell W, Leon A, Winokur G, et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry. 1996;153:483-489.
7. Weissman MM, Leaf PJ, Bruce ML, et al. The epidemiology of dysthymia in five communities: rates, risks, comorbidity , and treatment. Am J Psychiatr. 1988;145:815-819.
8. Major Depressive Disorder in Adults. Am J Psychiatr. 1993;150 (Supplement):2-26.
9. Yonkers KA, Chantilis SJ. Recognition of depression in obstetric/gynecology practices. Am J Obstet Gynecol. 1995; 173:632-638.
10. Weissman MM, Olfson M. Depression in women: implicationa for health care research. Science. 1995;269:799-801.
11. Cox JL, Holden JM, Sagovsky R. Detection of post-natal depression: Development of the ten-item post-natal depression scale. Br J Psychiatr. 1987;150:782-786.
12. Graze KK, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand. 1990; 81:201-205.
13. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA. 1993;269:2246-2248.
14. Miller LJ. Psychiatric medication during pregnancy: understanding and minimizing risks. Psychiatr Ann. 1994;24:69-75.
15. Wisner KL, Perel JM, Finding RL. Antidepressant treatment during breast-feeding. Am J Psychiatr. 1996;153:1132-1137.
16. Schatzberg AF, Nemeroff CB, eds. The American Psychiatr Press Textbook of Psychopharmacology. Washington: American Psychiatric Press, Inc., 1995:323-367.
17. Goodnick P. Verapamil prophylaxis in pregnant women with bipolar disorder (Letter). Am J Psychiatr. 193;150:1560.